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Background: Mutation in the Wiskott-Aldrich syndrome Protein (WASP) causes Wiskott-Aldrich syndrome (WAS),
X-linked thrombocytopenia (XLT) and X-linked congenital neutropenia (XLN). The majority of missense mutations
causing WAS and XLT are found in the WH1 (WASP Homology) domain of WASP, known to mediate interaction
with WIP (WASP Interacting Protein) and CIB1 (Calcium and Integrin Binding).
Results: We analyzed two WASP missense mutants (L46P and A47D) causing XLT for their effects on T cell
chemotaxis. Both mutants, WASPR
L46P and WASPR
A47D (S1-WASP shRNA resistant) expressed well in JurkatWASP-KD T
cells (WASP knockdown), however expression of these two mutants did not rescue the chemotaxis defect of
JurkatWASP-KD T cells towards SDF-1α. In addition JurkatWASP-KD T cells expressing these two WASP mutants were
found to be defective in T cell polarization when stimulated with SDF-1α. WASP exists in a closed conformation in
the presence of WIP, however both the mutants (WASPR
L46P and WASPR
A47D) were found to be in an open conformation
as determined in the bi-molecular complementation assay. WASP protein undergoes proteolysis upon phosphorylation
and this turnover of WASP is critical for T cell migration. Both the WASP mutants were found to be stable and have
reduced tyrosine phosphorylation after stimulation with SDF-1α.
Conclusion: Thus our data suggest that missense mutations WASPR
L46P or WASPR
A47D affect the activity of WASP in T
cell chemotaxis probably by affecting the turnover of the protein.
Keywords: Cell migration, Actin cytoskeleton, Proteosome, Cell polarity, Hematopoietic cell kinaseBackground
Wiskott-Aldrich Syndrome (WAS) is a rare X-linked reces-
sive disorder characterized by eczema, thrombocytopenia
(low platelet count, small size platelets), recurrent infec-
tions, autoimmune disorders and malignancies [1,2]. It was
first described in two brothers with chronic bloody diar-
rhea [3] and subsequently the X-linked pattern of inherit-
ance and platelet abnormalities were characterized [4]. The
gene affected in Wiskott Aldrich Syndrome was mapped to
chromosome region Xp11.23 and identified by positional
cloning [5]. The disease results from the mutations in a
502 amino acid protein known as Wiskott Aldrich Syn-
drome protein (WASP). Expression of WASP is restricted
to hematopoietic cells and it plays a key role in actin cyto-
skeleton reorganization [6].
WASP is a proline-rich adaptor with a WH1 (WASP
homology) domain at the N-terminal which mediates* Correspondence: thirumaran@ntu.edu.sg
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unless otherwise stated.interaction with WIP (WASP interacting domain) [7];
the C-terminal VCA (Verprolin Central Acidic) domain
stimulates the actin nucleation activity of the Arp2/3
complex [8]; the proline-rich domain before the VCA
domain mediates interaction with a number of SH3 do-
main containing proteins [9,10] and the GBD (GTPase
binding domain) mediates interaction with activated
Cdc42 (Rho family of GTPases) and relieves the auto-
inhibition [11]. Mutations in WASP gene can give rise
to three different clinical phenotypes; classical WAS, X-
linked thrombocytopenia (XLT) and X-linked severe
congenital neutropenia (XLN). In the case of classical
Wiskott Aldrich syndrome, WASP expression is absent
[12] and most of the patients die by 10 years of age
due to internal hemorrhages or recurrent bacterial or
viral infections [13]. Missense mutations resulting in re-
duced expression of defective WASP leads to X-linked
thrombocytopenia (XLT) which is characterized by
thrombocytopenia with small sized platelets without im-
munodeficiency or eczema [14]. X-linked neutropenia. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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WASP (L270P, S272P, I294T) which destroy the auto-
inhibitory conformation of WASP and enhanced its
actin polymerization activity [15,16].
A large number of point mutations in the WASP gene
have been identified from patients with different degrees
of severity [17], but the molecular mechanisms causing
the disease have not been characterized for most of the
mutations. More than 80% of the missense mutations are
located in the WH1 domain of WASP [10] and some
abolished WASP-WIP interactions [18,19] which cause in-
stability of WASP as WIP is a chaperone for WASP [20].
It is still not clear how the majority of the missense muta-
tions in the WH1 domain of WASP cause the disease.
Out of 52 WASP missense mutations reported, twelve of
the mutations are outside the WH1 domain and do not
impair the ability to suppress the growth defect of las17Δ
yeast strain suggesting that regulation of actin dynamic by
WASP is unaffected [18]. Our laboratory has carried out a
more comprehensive study of all 40 mutations present in
the WH1 domain of WASP and found that only 13 point
mutations out of 40 abolished formation of a functional
WASP-WIP complex in S. cerevisiae las17Δ strain [18].
Thus, it is still not clear how the majority of the remaining
point mutations cause the disease. The WH1 domain of
WASP has also been shown to interact with CIB1 (Calcium
and Integrin Binding) and this interaction is critical for
adhesion of platelets to fibrinogen [21]. CIB1 is a 22 kDa
EF-hand containing protein which is expressed ubiquitously
and identified as a binding partner of the cytoplasmic tail of
platelet integrin αIIbβ3 [22].
In this study, we have characterized two WASP mis-
sense mutations L46P and A47D in the WH1 domain
causing XLT. These two missense WASP mutants were
found to express well in JurkatWASP-KD T cells at levels
comparable to that of wild type WASP; however, expres-
sion of WASPR
L46P or WASPR
A47D did not rescue the
chemotaxis defect of JurkatWASP-KD T cells and the
JurkatWASP-KD T cells expressing the mutants displayed an
abnormal actin cytoskeleton and defective polarization after
stimulation with SDF-1α. While WASP exists in a closed
conformation in the presence of WIP, both WASPL46P and
WASPA47D mutants were found to be in open conform-
ation in the presence of WIP. While phosphorylation of
tyrosine residue promotes proteolytic degradation of wild
type WASP, both mutants were relatively stable and had re-
duced tyrosine phosphorylation after SDF-1α stimulation.
Our results suggest that these that mutations affect WASP
turnover resulting in defective chemotaxis.
Methods
Cell culture
Phoenix Amphotropic packaging cell line (ATCC, USA)
was maintained in DMEM/10% FBS at 37°C while Jurkat(clone E6-1) (ATCC, USA) were maintained in RPMI/
10% FBS at 37°C. JurkatWASP-KD T cells were generated
by transducing Jurkat T cells with retrovirus (generated
using amphotropic packaging cells) expressing human
WASP specific shRNA (S1-WASP shRNA) (GCAGGG
AATTCAGCTGAACAA) under the transcriptional con-
trol of the U6 promoter and GFP under the CMV pro-
moter. The infected cells were FACS sorted using GFP
fluorescence. We generated shRNA resistant WASP
(WASPR) mutants by introducing 4 silent mutations
(GCAAGGTATCCAACTGAACAA) in the region tar-
geted by the shRNA. WASPR or its mutants (tagged with
RFP at their C-terminus) were cloned in an EBV based
plasmid and expressed under the transcriptional regula-
tion of the WASP promoter. For expression of WASP or
its mutants in HEK293T cells, the gene was cloned
under the transcriptional regulation of the CMV pro-
moter in the pFIVcopGFP plasmid (System Biosciences).
Generation of stable cell lines
JurkatWASP-KD T cells were microporated with plasmid ex-
pressing WASPR-RFP (WT or mutants) using the Neon
transfection system (Invitrogen, CA, USA) according to
manufacturer’s instructions. In brief, 5 x 106 JurkatWASP-KD
T cells for each transfection were washed with PBS, resus-
pended in 100 μl of resuspension buffer (R-buffer) and
mixed with 10 μg of plasmid DNA. The cells-DNA mixture
was subjected to three pulses with pulse width 10 ms at
1500 V. Transfected cells after microporation were selected
with neomycin (G418, P02-012) (PAA Laboratories, Pasch-
ing, Austria) for one week (1.5 mg/ml) before analysis.
Medium containing G418 was changed once every 2 to
3 days for a week until the exogenous WASP was stably
expressed in the cells.
Chemotaxis assay using Dunn chamber
Sterilized coverslips were coated with 2 μg/ml fibronectin
in PBS for 1 hour at 37°C in a CO2 incubator before
adding 2.25 X 106, Jurkat T cells. The outer and inner well
of Dunn chamber (Hawksley & Sons Ltd, UK) [23] were
filled with complete RPMI media. The coverslip with
attached cells was then inverted onto the Dunn chamber
and media in the outer well was replaced with complete
RPMI media containing chemokine (5nM SDF-1α) (Pepro
Tech, London, UK). The coverslip was sealed using a
mixture of hot wax. Migrating cells on the annular bridge
were imaged using an inverted microscope (Olympus
IX81) with a 10X objective lens. Time-lapsed images were
digitally captured every 2 minutes for a period of 3 hours
using a CoolSNAPHQ camera. Migration paths of the cells
were traced and analyzed from the series of images using
Metamorph software (Molecular devices, CA, USA).
Twenty cells were analyzed for each set of experiment and
each experiment was repeated thrice.
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JurkatWASP-KD T cells expressing various WASPR mu-
tants were serum starved for two hours and 2 x 105 cells
in 100 μl RPMI were added to the upper chamber of a
transwell (5.0 μm pore size) (Costar, Cambridge, MA).
The lower well was filled with 600 μl containing 100 ng/
ml of SDF-1α and incubated at 37°C for 3 hours in CO2
incubator. Cells in the lower well were counted using a
hemocytometer. The percentage of cells migrated was
calculated as the ratio of the number of cells detected in
the lower well over the total cell number.
Immunofluorescence and BiFC
Jurkat T cells or JurkatWASP-KD T cells expressing WASPR
or mutants were resuspended in RPMI-1640 media con-
taining 25 mM HEPES (pH 7.4) and incubated for 20 min
at 37°C, CO2 incubator. Cells after incubation were plated
on poly-L-lysine coated coverslips and allowed to attach
for 10 min. Attached cells were stimulated with SDF-1α
(10 nM) for 5 min and fixed (4% formaldehyde/PBS) for
20 min. The fixed cells were permeabilized (0.2% Triton
X-100/PBS) for 30 min, blocked with 1% BSA/PBS,
washed three times and stained with Alexa594 phalloidin
(Molecular probes, Eugene, Oregon, USA). Fluorescent
images were acquired using an Olympus microscope fitted
with Photometrics CoolSNAPHQ2 camera. The experi-
ment was repeated at least three times and 40 cells were
evaluated for each experiment.
Bi-molecular Fluorescence Complementation (BiFC)
was carried out as described previously [24,25]. In brief,
a WASP (WT or mutants) sensor construct was co-
transformed with WIP in an S. cerevisiae yeast strain.
The transformed yeast cells were visualized for fluores-
cence using an Olympus microscope with CoolSNAPHQ
camera (Roper scientific) and fluorescence intensity was
calculated using Metamorph software. Similar experi-
ments were performed in mammalian HEK293T cells. In
brief, HEK293T cells were co-transfected with WIP-His
and WASP (WT or mutants) sensors. After 36 hours of
transfection, the cells were visualized and the fluores-
cence intensity of the transfected cells was quantified
using Metamorph software.
Proteasome inhibition study and immunoblotting
WASPR-RFP (WT or mutants) expressing Jurkat T cells
were incubated with proteasome inhibitor MG132 (50 μM)
(Enzo Life Sciences, Plymouth Meeting, PA, USA) or cal-
pain inhibitor Calpeptin (50 μg/ml) (Calbiochem, San
Diego, CA, USA) for 5 h. After incubation, cells were lysed
using RIPA lysis buffer, the resulting lysate (30 μg of pro-
tein) was boiled in a SDS-PAGE sample buffer, resolved on
a 10% SDS-PAGE gel and transferred onto a nitrocellulose
membrane. The membrane was probed with primary anti-
body (WASP D1, Santa Cruz Biotechnology, CA, USA)followed by secondary antibody conjugated with horse rad-
ish peroxidase (HRP). Anti-GAPDH (Ambion, Austin, TX,
USA) was used as a loading control. S. cerevisiae cell lysis
was performed as described [18]. In brief, yeast cells were
harvested by centrifugation and the pellet resuspended in
1.85 N NaOH/1.0 M β-mercaptoethanol. The protein in
the lysate was precipitated using 20% trichloroacetic acid
(TCA) and protein pellet was washed once with cold acet-
one. The protein was resuspended in SDS page loading
buffer and analysed with appropriate primary antibodies.
For analysis of WASP phosphorylation after activation
with chemokine SDF-1α, Jurkat T cells expressing WASP
or His-tagged mutants were serum-starved overnight
followed by activation with SDF-1α (100nM) for 5 min.
Cells were lysed immediately and His-tag pull down was
performed. Pull down samples were analysed by western
blot using anti-His (WASP) (Delta biolabs, Gilroy, CA,
USA) and anti-phosphotyrosine (4G10; Upstate Biotech-
nology, Lake Placid, NY) antibodies. In addition, WASP
or His-tagged mutants were expressed together with acti-
vated Cdc42 (Cdc42G12V) in HEK293T cells. Thirty-six
hours post-transfection, the cell lysate was prepared and a
His-tag pull down assay was performed. The tyrosine
phosphorylation status of the WT and mutant WASP was
assessed by western blot using the 4G10 antibody.
Statistical analysis
Statistical significance analysis was performed using un-
paired student’s t-test and p < 0.05 was considered statisti-
cally significant. Values presented in bar charts represent




A47D does not rescue the
chemotactic response of JurkatWASP-KD T cells to SDF-1α
A large numbers of missense mutations in the WH1 domain
of WASP have been linked to Wiskott Aldrich Syndrome
and XLT [10]. WIP binds to the WH1 domain of WASP
(residues 101–151) and stabilizes the closed conformation of
WASP [25] and protects WASP from calpain mediated
proteolysis [19,20,26]. CIB1 binds to the WHI domain of
WASP (residues 1–100) and this complex is critical for
αIIbβ3-mediated cell adhesion and platelet aggregation
[21]. In this study, we analyzed twenty-five missense mu-
tants in the WH1 domain of WASP for their interaction
with CIB1 and found six of the WASP mutations (G40V,
T45M, L46P, A47D, P58L, G70W) abolished WASP-CIB1
interaction without affecting WASP-WIP interaction
(Additional file 1: Figure S1). Three of the WASPWH1 mis-
sense mutations have been reported to cause WAS
(WASPG40V, WASPP58L and WASPG70W) and the remaining
three mutations (WASPT45M, WASPL46P, WASPA47D) have
been reported to cause XLT [10]. XLT is characterized by





Figure 1 WASP knockdown Jurkat T cells are impaired in chemotaxis towards SDF-1α. A) Jurkat T cells were transduced with retrovirus
expressing human WASP specific shRNA and EGFP. The cells were FACS sorted and the efficiency of knock down was determined by western blot using
anti-WASP and anti-GAPDH antibody. B) WASP mRNA levels in Jurkat T cells and JurkatWASP-KD T cells were quantified by real-time PCR. ***P < 0.001
compared to WT Jurkat T cells. C) Vector plots of migration paths of 20 randomly chosen cells from WT Jurkat T cells or JurkatWASP-KD T cells exposed to a
gradient of SDF-1α in the Dunn chamber. The starting point of each cell is at the intersection of the X and Y axes. The source of SDF-1α was at the top. D)
Migration velocity of WT and JurkatWASP-KD T cells shown as the mean of the velocities of 60 randomly chosen cells (20 cells each from 3 sets of experiments)
*p < 0.05. E) Circular histograms showing the percentage of cells at the final positions in each of the sectors (20°). The source of SDF-1α was at the top. F)
Transwell migration assay was performed with WT Jurkat T cells and JurkatWASP-KD T cells. 2 X 105 cells were loaded in upper well and allowed to migrate
towards SDF-1α (100 ng/ml) containing media in the lower well for 3.0 hrs. Cells migrated to the lower well were counted and plotted as percentages of
total cells added to the upper well. Data represent the mean of three independent experiments. **p < 0.01 compared to WT Jurkat T cells.
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mutants in Jurkat T cells, we first generated WASP spe-
cific shRNA (S1-WASP-shRNA) to knock down the
expression of endogenous WASP. WASP and N-WASP
have more than 50% sequence homology [28]. We there-
fore tested the specificity of S1-WASP-shRNA by co-
transfecting HEK293T cells with expression plasmids for
S1-WASP-shRNA and either human N-WASP orWASP. We found that the S1-WASP-shRNA did not
target human N-WASP (data not shown). We generated
S1-WASP-shRNA expressing retrovirus by transfection
of amphotropic packaging cells [29]. The virus super-
natant was used to transduce Jurkat T cells using spino-
culation at a transduction efficiency of 43% (data not
shown). The transduced Jurkat T cells stably expressing
GFP were sorted by flow cytometry (data not shown)
Jain et al. Journal of Biomedical Science 2014, 21:91 Page 5 of 12
http://www.jbiomedsci.com/content/21/1/91and propagated. Western blot analysis of sorted
JurkatWASP-KD T cells showed effective knockdown of
endogenous WASP expression (Figure 1A). This was
further validated by qPCR which showed that mRNA
level of WASP in JurkatWASP-KD T cells was reduced by
68% compared to WT Jurkat T cells (Figure 1B). WASP
has been shown to be critical for T cell chemotaxis [30].
Consistent with previous studies, our JurkatWASP-KD T
cells were defective in their chemotactic response to the
chemokine SDF-1α as assessed in Dunn chamber
(Figure 1C-E). Compared to 85% of WT Jurkat T cells,
only 15% of JurkatWASP-KD T cells were found in the 40°
arc facing the chemokine source (Figure 1E). Moreover
the migration velocity of JurkatWASP-KD T cells (0.98 μm/
min) was significantly reduced compared to WT Jurkat
T cells (1.84 μm/min) (Figure 1D). The defect in chemo-
taxis of JurkatWASP-KD T cells was further confirmed by
transwell assays (Figure 1F). In order to express the
WASP mutants in JurkatWASP-KD T cells, we generated
WASPR, WASP which is resistant to the S1-WASP-
shRNA by introduction 4 silent mutations at the region
of WASP gene targeted by shRNA. The expression level
of WASP and WASPR was found to be comparable
when tested in both HEK293T cells and Jurkat T cells
(Additional file 2: Figure S2A, B) which suggest that the
introduction of silent mutations in WASP gene does not
affect the translation efficiency of the protein. The genes
encoding WASP or its mutants were placed under the
transcriptional regulation of the human WASP pro-









with RFP were microporated into JurkatWASP-KD T cells
and selected with neomycin for one week before analyz-
ing the WASP expression by western blotting. The
expression of WASPR
L46P and WASPR
A47D can be read-






G70W) were decreased (Figure 2A). This decrease
is due neither to any defect at the transcription level
(Figure 2B) nor to any changes in WIP expression levels
(Figure 2A). However, all six mutants express well in
HEK293T cells suggesting that the reduced expression
of the four WASP mutants was restricted to T cells
(Additional file 2: Figure S2C, D). WIP is known to
interact with the WH1 domain of WASP and protect
WASP from cytoplasmic proteases [20]. Reduced ex-
pression of these four WASP mutants in T cells could be
the possible cause of the disease in patients harboring
these mutations. None of the six mutations affected
interaction with WIP (Additional file 1: Figure S1), indi-
cating that instability was not due to loss of interaction
with WIP. This may indicate that WIP is not the only
chaperone for WASP in T cells.The effect of proteasome (MG132) and calpain (cal-
peptin) inhibitors on the expression level of WASP and
its mutants was examined. We found that pre-
incubation of Jurkat T cells expressing the WASPR WT
and mutants (G40V, T45M, P58L and G70W) with
MG132 resulted in significant increase in WASP expres-
sion level (WASPR, 1.8 ± 0.19 fold; G40V, 1.6 ± 0.30 fold;
T45M, 1.8 ± 0.40 fold; P58L, 1.5 ± 0.02 fold; G70W, 1.9 ±
0.30 fold) (mean of three experiments). However, there
was no significant increase in mutants (L46P and A47D)
expression level observed after MG132 treatment (L46P,
1.34 ± 0.50 fold; A47D, 1.1 ± 0.15 fold). Pre-incubation of
Jurkat T cells expressing all six WASP mutants with cal-
peptin did not result in an increase in expression com-
pared to significant increase in WT WASP expression.
Thus all together results suggest that four WASP mu-
tants (G40V, T45M, P58L and G70W) are unstable in
Jurkat T cells due to their proteasome mediated
degradation.
The two mutants (WASPR
L46P, WASPR
A47D) which
are stable and readily detected in JurkatWASP-KD T cells
were analyzed for their ability to rescue chemotaxis




failed to rescue the chemotactic defect of JurkatWASP-KD
T cells, unlike the WASPR-RFP (Figure 3A). Quantita-
tive analysis revealed that the migration speed of
JurkatWASP-KD T cells expressing WASPR
L46P-RFP
(1.46 μm/min) or WASPR
A47D-RFP (1.36 μm/min) was
significantly reduced compared to JurkatWASP-KD T cells
expressing the WASPR-RFP (2.3 μm/min) (Figure 3B).
Circular histogram showing the overall directionality of
cell migration revealed that 86.6% of JurkatWASP-KD T
cells expressing WASPR-RFP moved to a position within
the 40° of arc facing the chemokine source. By contrast




ively moved to this position, comparable to control
urkatWASP-KD T cells expressing RFP alone (10% of
total). Thus, the WASPR
L46P or WASPR
LA47D mutants
do not rescue the chemotactic defect of JurkatWASP-KD
T cells (Figure 3C).
To confirm the chemotactic migration defect of
JurkatWASP-KD T cells expressing WASPR
L46P-RFP or
WASPR
A47D-RFP, a transwell migration assay was per-
formed. We found that 41.3% of WASPR
L46P-RFP or
44.4% of WASPR
A47D-RFP expressing JurkatWASP-KD T
cells migrated to the lower well compared to 57.5% of
WASPR-RFP expressing cells suggesting that WASPR
L46P
or WASPR
A47D mutants are unable to rescue the impaired
chemotaxis of JurkatWASP-KD T cells towards SDF-1α
(Figure 3D). Taken together these results suggest that the
missense mutation (WASPL46P or WASPA47D) abolished
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Figure 2 WASP mutants WASPR
L46P and WASPR
A47D are stably expressed in JurkatWASP-KD T cells. A) JurkatWASP-KD T cells expressing RFP
or WASPR-RFP fusions (WT or mutants) were generated by microporating Jurkat
WASP-KD T cells with plasmids expressing the constructs under the
transcriptional regulation of WASP promoter followed by one week of selection with neomycin. The cell lysate were resolved and probed with either anti-
WASP, anti-WIP and anti-GAPDH antibodies. B) Total RNA from JurkatWASP-KD T cells expressing WASP-RFP fusions or mutant derivatives were isolated and
used to carryout quantitative real time PCR analysis to analyze expression of WASP or its mutant at mRNA level. C) Jurkat T cells expressing the RFP tagged
WT or mutants WASP were incubated with either MG132 or calpeptin for 5 hours. Cells were lysed and immunoblotted for WASP and GAPDH antibodies.
Jain et al. Journal of Biomedical Science 2014, 21:91 Page 6 of 12
http://www.jbiomedsci.com/content/21/1/91Abnormal actin cytoskeleton reorganization of
JurkatWASP-KD T cells expressing WASPL46P and WASPA47D
mutants in response to SDF-1α stimulation
The actin cytoskeleton plays a critical role in chemotaxis
and WASP regulates the actin cytoskeleton [31] and results
from previous section suggests that expression of either of
the WASP missense mutants (WASPR
L46P or WASPR
A47D)did not rescue the chemotaxis defect of JurkatWASP-KD T
cells towards chemokine SDF-1α (Figure 3). SDF-1α has
been shown to regulate actin cytoskeleton reorganization
and cell polarization [32]. In order to investigate the
reorganization of the actin cytoskeleton in response to
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Figure 3 Expression of WASPL46P or WASPA47D does not rescue the chemotaxis defect of JurkatWASP-KD T cells. A) Vector plots of migration
paths of 20 randomly chosen cells from JurkatWASP-KD T cells expressing RFP, WASPR-RFP, WASPR
L46P-RFP, WASPR
A47D-RFP exposed to a gradient of SDF-1α
in the Dunn chamber. Time-lapse images were captured for 3 hours at 2.0 min intervals. The starting point of each cell is at the intersection of the X and Y
axes. The source of SDF-1α was at the top. B) Migration velocity of each cell type as in panel A, mean of velocities of 60 randomly chosen cells (20 cells
each from 3 sets of experiments) * P < 0.05 compared to JurkatWASP-KD T cells expressing WASPR-RFP. C) Circular histograms showing percentage of cells at
their final positions in each of the sectors (20°). The source of SDF-1α was at the top. D) In transwell migration assay, cells were loaded in upper well and
allowed to migrate towards SDF-1α (100 ng/ml) containing media in the lower well for 3.0 hours. Cells migrated to the lower well were counted and the
percentage of cells migrated to the lower well was calculated. Data represent the mean of three independent experiments. * P < 0.05, ** P < 0.01.
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Unstimulated cells, WT Jurkat T cells or JurkatWASP-KD T
cells expressing WASP or its mutants exhibited a ring of
actin at the cell periphery. Upon stimulation with SDF-1α,
more than 50% of the Jurkat T cells or JurkatWASP-KD T
cells expressing WASPR lost their rounded morphology
and exhibited a polarized actin cytoskeleton with one
prominent patch of actin (Figure 4A). In contrast
JurkatWASP-KD T cells or JurkatWASP-KD T cells expressing
mutants had a reduced percentage of cells (~25 to 30%)
with actin polarized to one pole and most of them (~55%)
retained a rounded shape. A fraction (>20%) of JurkatWASP-
KD T cells or JurkatWASP-KD T cells expressing WASPmutants exhibited abnormal polarization with multiple
patches of actin after stimulation with SDF-1α while less
than 10% of Jurkat T cells or JurkatWASP-KD T cells express-
ing WASPR had more than one pole after stimulation
(Figure 4B). This suggests that the abnormal actin cytoskel-
eton organization could account for the observed chemo-
tactic defect of JurkatWASP-KD T cells expressing WASP
mutants.
WASP mutants (WASPL46P and WASPA47D) exists in open
conformation
WASP exists in two different conformations. In its resting
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Figure 4 JurkatWASP-KD T cells expressing WASP mutants exhibit abnormal actin cytoskeleton reorganization upon SDF-1α stimulation.
A) WT or JurkatWASP-KD T cells expressing WASPR or mutants were plated on poly-L-lysine coated coverslip, stimulated for 5 min with SDF-1α, fixed
and stained with Alexa 594 phalloidin. Arrows indicate the actin patches. B) Quantification of actin polarization from three independent experiments
as described in materials and methods. **p < 0.01 compared to WT Jurkat T cells.
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family GTPases, such as Cdc42 and tyrosine kinases bind
and activate WASP [9,33] by inducing a conformational
change. In order to study the effect of missense mutations
on the conformation of WASP, a Bi-molecular Fluorescence
Complementation (BiFC) assay was performed [25]. The
YFP molecule was split into two fragments; for the WASP
and its mutants (WASPR
L46P or WASPR
A47D) YFP1–154 was
fused to the N-terminus while YFP155–238 was fused to the
C-terminus to generate the WASP sensor (NLS-YFP1–154-
WASP-YFP155–238) or corresponding WASP mutant sen-
sors. The NLS localizes the sensor to the nucleus which
protects it from cytoplasmic proteases [25]. It has been re-
ported that 95% of WASP exists as a complex with WIP
[34]. Thus we expressed NLS-WASP or mutant sensor to-
gether with NLS-WIP in yeast cells. The fluorescence inten-
sity of cells was calculated as described previously [25]. We
found that fluorescence intensity of both WASP mutant
sensors was reduced compared to the WASP sensor in thepresence of WIP (Figure 5A and B). The reduced fluores-
cence intensity of WASP mutant sensors in the presence of
WIP was not due to their poor expression compared to
WASP sensor (Figure 5C). We further analyzed the con-
formation of WASP and its mutants in a mammalian
system. WASP or mutant sensors were co-transfected
with WIP in HEK293T cells. After 36 hours of transfec-
tion, fluorescence intensity of the cells was observed
and quantified. Similar to the results obtained in yeast,
the fluorescence intensity of WASP was increased in
the presence of WIP, suggesting that WASP exists in
its closed conformation. However, the fluorescence in-
tensity of WASP mutants was significantly reduced
even in the presence of WIP (Figure 5D-F). The re-
duced fluorescence intensity of the mutant WASP
sensors (WASPL46P and WASPA47D) was not due to re-
duced expression or decreased interaction with WIP






Figure 5 WASP mutants exist in open conformation even in the presence of WIP. A) S. cerevisiae cells expressing NLS-WASP-Sensor or mutant
(L46P, A47D) sensors + NLS-WIP were grown to exponential phase at 24°C and analyzed by fluorescence microscopy. B) Quantification of fluorescence
intensity of S. cerevisiae cells expressing NLS-WASP-Sensor or mutants (L46P, A47D) + NLS-WIP. ***p < 0.001 compared to NLS-WASP +NLS-WIP expressing
cells. C) Western blot analysis of S. cerevisiae cells expressing of NLS-WASP-Sensor or mutants + NLS-WIP using anti-GFP, anti-WIP and anti-Hexokinase
serum. D) HEK293T cells were co-transfected with WASP or mutants (L46P, A47D) sensor with WIP and analyzed by fluorescence microscopy.
E) Quantification of fluorescence intensity of WASP or mutants (L46P, A47D) in the presence of WIP. ***p < 0.001 compared to WASP sensor +WIP
expressing cells. F) Western blot analysis of HEK293T cells expressing WASP or mutant sensors with WIP using anti-GFP (WASP), anti-His (WIP) and
anti-GAPDH. G) His tag pull down assay showing the interaction of WASP or mutants (L46P, A47D) (tagged with GFP) with WIP-His in HEK293T cells.
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tyrosine phosphorylation after SDF-1α stimulation
WASP has been shown to be activated by many binding
partners. One of the mechanisms for WASP activation is
mediated by binding of Cdc42 to the GTPase binding do-
main of WASP. This provokes the release of WASP from
its inhibited state and contributes to subsequent WASP
tyrosine phosphorylation [35-37]. In our study, co-
expression of WASP with activated Cdc42 (Cdc42G12V) in
HEK293T cells resulted in increased WASP tyrosine phos-
phorylation (Figure 6A), supporting previous studies
whereby Cdc42 relieved the WASP auto-inhibitory con-
formation and increased the accessibility of WASP to cellu-
lar kinases [38-40]. Compared to WASP, phosphorylation
of WASP mutants (L46P, A47D) was significantly reduced
(Figure 6A). Moreover, we found that the phosphorylation
of mutant WASP was significantly reduced in Jurkat T cells
after stimulation with SDF-1α (Figure 6B). Previous studies
have shown that SDF-1α stimulation activates Cdc42 which
is required for WASP-Cdc42 interaction and thus critical
for T cell chemotaxis [30]. Although the two WASP muta-
tions (L46P, A47D) do not affect WASP-Cdc42 interaction
(data not shown), these mutations affected the WASPconformation and thus its phosphorylation, which is critical
for T cell chemotaxis.Discussion
WASP is a multi-domain proline-rich protein which reg-
ulates the actin cytoskeleton by modulating the actin nu-
cleation activity of the Arp2/3 complex [41]. Most of the
missense mutations causing WAS/XLT are found in the
WH1 domain of WASP [10] and it has been suggested
that loss of interaction with WIP is causal for the disease
[19]. However we have previously shown that the majority
of the mutations in the WH1 domain do not affect the for-
mation of a functional WASP-WIP complex [18]. In order
to characterise the molecular defect of the other mutations
in the WH1 domain we screened twenty-five WASP mis-
sense mutations for interaction with CIB1 and found
six WASP missense mutants (WASPG40V, WASPT45M,
WASPL46P, WASPA47D, WASPP58L and WASPG70W) that
are defective in binding to CIB1, but not to WIP
(Additional file 1: Figure S1). Four of the missense WASP
mutants (WASPG40V, WASPT45M, WASPP58L, WASPG70W)
were found to be relatively unstable in JurkatWASP-KD T
0.58     1.0    0.38    0.56















Figure 6 WASPL46P and WASPA47D mutants have reduced
tyrosine phosphorylation after SDF-1α stimulation. A) HEK293T
cells expressing WASPR or mutants (L46P, A47D) (tagged with His
tag) together with or without activated form of Cdc42 (Cdc42G12V).
Thirty-six hours after transfection, a His-tag pull down assay was
performed and analyzed by western blot for WASP (anti-His), Cdc42 and
4G10 (anti-phosphotyrosine antibody). B) Jurkat T cells expressing WASPR
or its mutants (L46P, A47D) (tagged with His tag) were stimulated with
SDF-1α for 5 min and lysed. His tag pull down assay was performed and
analyzed by western blot for phosphorylation of WASP or its mutants
(L46P, A47D) using 4G10 antibody.
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proteasome inhibitor (Figure 2). Thus, suggest that these
WASP mutations reduce stability by increasing proteasome-
mediated degradation. Moreover these four WASP mutants
were expressed well in HEK293T cells which suggest that
the reduced expression of the four WASP mutants was T
cell specific (Additional file 2: Figure S2C, D) and also indi-
cates that WIP is not the only chaperone for WASP in
T cells. The expression of the other two missense
mutants (WASPL46P and WASPA47D) were readily de-
tected (Figure 2A).
JurkatWASP-KD T cells were defective in their chemotac-
tic response to the chemokine SDF-1α (Figure 1C, D, E, F)




the chemotaxis defect (Figure 3). CIB1 has been shown topromote megakaryocyte migration towards SDF-1α [42]
and expression of CIB1 has been reported to be upregu-
lated in breast cancer tissue [43] suggesting a regulatory
role for CIB1 in cell migration. Thus, the loss of inter-
action of WASPL46P or WASPA47D with CIB1 could be
one of the reasons for defective chemotaxis of JurkatWASP-KD
T cells expressing the WASP mutants.
Analysis of actin cytoskeleton organization after SDF-1α
stimulation revealed that cells expressing either the
WASPL46P or WASPA47D mutants were impaired in actin
cytoskeleton reorganization as most of the cells exhibited a
rounded shape and a significant number of cells had more
than one pole (Figure 4). Polarization of T-lymphocytes in
response to chemokine stimulation is essential for chemo-
taxis as inhibition of lymphocytes polarization by pentoxi-
fylline inhibits their chemotactic response [44]. Thus, the




presence of chemokine SDF-1α could account for their im-
paired chemotaxis.
WASP exists in two conformations, an open active con-
formation and a closed inactive conformation which is
stabilized by WIP [11,25]. Binding of activated Cdc42 and/
or phosphorylation of tyrosine291 relieves the auto-
inhibition and promote activation of the Arp2/3 complex
[36]. While WASP was in a closed conformation in the
presence of WIP, both WASPL46P and WASPA47D were
found to be in an open conformation even in the presence
of WIP (Figure 5) suggesting defects in the conform-
ational regulation of WASP in these two mutants. Expres-
sion of WASPL46P-RFP or WASPA47D-RFP was elevated
compared to WASPR-RFP expression in Jurkat
WASP-KD T
cells suggesting that the mutations might have increased
the stability of WASP. Moreover, co-expression of WASP
with Hck (hematopoietic cell kinase) in HEK293T cells
caused degradation of WASP, while co-expression of
WASP mutants with Hck did not result in proteolytic deg-
radation of WASP mutants (Additional file 3: Figure S3).
This suggests that the WASP mutants (WASPR
L46P or
WASPR
A47D) are highly stable. Turnover of WASP is es-
sential for chemotaxis as inhibition of calpain mediated
WASP turnover resulted in impairment in migration of
dendritic cells [45]. Compared to WT WASP, the phos-
phorylation of both mutants was reduced when expressed
together with activated Cdc42 (Cdc42G12V) in HEK293T
cells (Figure 6A). In addition, both the mutants had re-
duced tyrosine phosphorylation in Jurkat T cells activated
with chemokine SDF-1α (Figure 6B). Tyrosine phosphor-
ylation of WASP has been shown to target WASP for pro-
teasome mediated degradation which is critical for WASP
turnover [46]. The reduced tyrosine phosphorylation of
WASP mutants in Jurkat T cell stimulated with SDF-1α is
probably the cause of their increased stability and hence
the altered chemotactic response.
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We have found that two WASP mutations (L46P and
A47D) causing XLT affect the function of WASP in T
cell chemotaxis. JurkatWASP-KD T cells expressing these
mutants were found to have abnormal actin cytoskeleton
reorganization upon stimulation with SDF-1α. These
two mutations keep WASP in an open conformation but
reduced tyrosine phosphorylation following SDF-1α
stimulation leading to enhanced WASP stability. The
turnover of WASP is essential for chemotaxis and these
two mutations probably affect the activity of WASP in
this process by enhancing the stability of WASP.
Additional files
Additional file 1: Figure S1. Six missense mutations in the WH1
domain abolish WASP-CIB1 interaction. (A) Yeast two hybrid strains
harboring Gal4 DNA-Binding domain-WASP1–265 (WT or its mutants) and
Gal4 Activation Domain-CIB1 fusion were streaked on selective plates
(−T-L: minus Tryptophan/Leucine or –T-L-H: minus Tryptophan/Leucine/
Histidine). The plates were incubated at 30°C and photographed after 5 days.
(B) Mutations affecting WASP-CIB1 interaction do not affect WASP-WIP
complex formation. S. cerevisiae strain PJ69-4A was co-transformed with
plasmids expressing the BD-WASP or WASPWH1 mutant’s fusion proteins
and the AD-WIP or empty vector. The transformed colonies were streaked
on SD minimal media plates lacking Tryptophan/Leucine or Tryptophan/
Leucine/Histidine and incubated at 30°C for 5 days.
Additional file 2: Figure S2. WASP missense mutants are stably
expressed in HEK293T cells. Expression of wild type WASP-RFP and
WASPR-RFP (S1-WASP-shRNA resistant) in HEK293T cells (A) and Jurkat T
cells (B) was analyzed by immunoblot using anti-WASP antibody. (C). WASP or
its mutants tagged with GFP were expressed in HEK293T cells and analyzed
for their expression using fluorescence microscope and by western blot (D)
using anti-GFP antibody.
Additional file 3: Figure S3. WASP mutants (WASPL46P and WASPA47D)
are stable in the presence of Hck. WASPR or its mutants tagged with His
tag were expressed in HEK293T cells together with either GFP or
Hck-GFP. The cells were lysed and immunoblot analysis was carried with
anti-His (WASP expression), anti-GFP (Hck or GFP) and GAPDH.
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